Milner Institute Panel Discussion
About the Speakers
Prof. Tony Kouzarides, FMedSci, FRS
Tony Kouzarides is a professor of Cancer Biology at the University of Cambridge. He is a Senior Group Leader at the Gurdon Institute and director/co-founder of the Milner Therapeutics Institute. Tony did his PhD at the University of Cambridge and postdoctoral work at the MRC Laboratory of Molecular Biology and New York University Medical Center. His research group at the Gurdon Institute is focused on epigenetic modifications and their involvement in cancer. Tony is co-founder of Abcam plc, a research reagents supplier based on the Cambridge Biomedical Campus, Storm Therapeutics, a drug discovery company based in on the Cambridge Babraham Campus, and Chroma Therapeutics, based in Oxford. He is the founder and director of Cambridge Gravity, an organisation that supports Cambridge Science and the founder of a cancer charity in Spain (Vencer el Cancer). He is the senior treasurer of Building Bridges in Medical Sciences.
Dr Jason Mellad
Jason is a scientist entrepreneur passionate about translating innovative technologies into better patient outcomes. As CEO and co-founder of Start Codon, a Cambridge based venture builder, he aims to identify the most disruptive healthcare founders and innovations worldwide, seed fund them and leverage the exceptional resources of the Cambridge cluster to de-risk and drive the success of their start-ups. He was previously the CEO of Cambridge Epigenetix and Business Development Manager for Horizon Discovery’s diagnostics division. He also served as an associate at Cambridge Enterprise, the technology transfer office of the University of Cambridge.